Advancing Cancer Therapy: Harnessing In Vivo Tumor Models for Breakthrough Drug Development

Registration link:

https://www.eventbrite.com/e/1021029977147?aff=oddtdtcreator

Date:

Wednesday, Oct 2nd, 2024; 11:00 am PST, or 2:00 pm EST

Webinar Highlights:

Join us for an insightful webinar exploring the critical role of in vivo tumor models in advancing cancer drug therapy. We will provide an overview of the diverse tumor models developed by our company, highlighting case studies demonstrating their effectiveness in preclinical cancer research. The session will delve into the comprehensive use of gene-modified cell lines and genetically modified spontaneous mouse models, showcasing their application in mimicking human cancer biology. We will conclude with a brief introduction to our company and our commitment to accelerating cancer drug development through innovative animal modeling services.

This webinar is ideal for researchers, drug developers, and anyone involved in cancer therapy seeking to understand the latest advancements in tumor modeling.

Meet Our Speaker:

Dr. Juan (Jane) Hong earned her Bachelor's degree and Ph.D. from Nanjing Medical University in 2017, specializing in neuroinflammation and molecular biology related to central nervous system (CNS) diseases. She then furthered her research at the University of Nebraska and Washington University in St. Louis, dedicating six years to studying biomarkers across various diseases, with a particular focus on immuno-oncology. In 2022, Jane joined the International Industrial Client Department at GenoBioTX as a Senior Marketing Manager, where she has been involved in numerous projects evaluating small and large molecules in various cancer models. Her career has been marked by extensive experience in developing and assessing drug candidates in preclinical models.

About GenoBioTX

GenoBioTX provides comprehensive animal modeling services, ranging from model construction to preclinical in vitro and in vivo assays, based on the combination of versatile technical platforms and experienced scientist.

Contact us

Website: www.genobiotx.com
Email: info@genobiotx.com
Address: 10410 Corporate Dr., Sugar Land, TX, 77478, USA

    News Center

    2024.11.01

    How to Verify Your Cre-lox Model

    Now that the genetically engineered mice that carry a Cre-conditional (“floxed”) allele in target gene are at your hand. And the mice are supposed to express Cre in target tissue. The validation of your Cre-lox model become very indispensable, so here we advise you of some essential steps. Genotype the mice When unexpected phenotypes are observed during your working with mice, the […]

    2024.11.09

    Advancing Cancer Therapy: Harnessing In Vivo Tumor Models for Breakthrough Drug Development

    Registration link: https://www.eventbrite.com/e/1021029977147?aff=oddtdtcreator Date: Wednesday, Oct 2nd, 2024; 11:00 am PST, or 2:00 pm EST Webinar Highlights: Join us for an insightful webinar exploring the critical role of in vivo tumor models in advancing cancer drug therapy. We will provide an overview of the diverse tumor models developed by our company, highlighting case studies demonstrating […]

    Email Back to top